世界の製薬産業分析2015...市場調査レポートについてご紹介

【英文タイトル】Analyzing the Global Pharmaceutical Industry 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Executive Summary

Section 1: Analyzing the Global Pharmaceutical Industry

A. Historical Perspective of the Global Pharmaceutical Industry

B. Analysis of the Global Pharmaceutical Industry
B.1 Industry Definitions
B.1.1 Pharmaceutical Industry
B.1.2 Bulk Drugs
B.1.3 Formulations
B.2 Industry Statistics
B.3 Industry Value Analysis
B.4 Market Segments
B.5 Market Share Analysis
B.6 Competition in the Industry
B.7 Market Forecast

C. Global Pharmaceutical Industry: Porter’s Five Forces Strategy Analysis
C.1 Introduction
C.2 Bargaining Power of Buyers
C.3 Bargaining Power of Suppliers
C.4 Competitive Rivalry in the Industry
C.5 Threat of New Entrants
C.6 Threat of Substitutes

D. Analysis of the Global OTC Pharmaceutical Industry
D.1 Industry Definition
D.2 Industry Statistics
D.3 Industry Value Analysis
D.4 Market Segments
D.5 Distribution Channels
D.6 Market Share Analysis
D.7 Market Forecast

E. Global OTC Pharmaceutical Industry: Porter’s Five Forces Strategy Analysis
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes

F. Analysis the Global Generics Industry
F.1 Industry Definition
F.2 Industry Statistics
F.3 Industry Value & Volume Analysis
F.4 Market Segments
F.5 Industry Structure
F.6 Patent Expiries
F.7 Patent Expiries by Therapeutic Areas
F.8 Research & Development in the Industry
F.8.1 Super Generics
F.8.2 Biosimilars
F.9 Market Forecast

G. Global Generics Industry: Porter’s Five Forces Strategy Analysis
G.1 Introduction
G.2 Bargaining Power of Buyers
G.3 Bargaining Power of Suppliers
G.4 Competitive Rivalry in the Industry
G.5 Threat of New Entrants
G.6 Threat of Substitutes

H. Structure of the Global Pharmaceutical Industry
H.1 R&D Pipelines
H.2 Defense against Generic Competition
H.3 Looking at Restructuring and Outsourcing
H.4 Strategic Alliances

I. Analyzing the Industry
I.1 Barriers to Entry
I.2 Lifecycle of a Drug
I.2.1 The Patent System
I.2.2 Drug Lifecycle
I.3 Industry Cost Structure
I.3.1 Types of Costs
I.3.2 Evidence on Cost Structure
I.3.3 Increasing Costs & Risks of Developing New Drugs
I.3.4 Conclusion
I.4 Trends in the Global Pharmaceutical Industry
I.5 Business Environment
I.6 Industry Innovation
I.7 Globalization of the Pharmaceutical Industry
I.8 Role of Genomics

J. Factors Driving Growth & Change in the Global Pharmaceutical Industry
J.1 Introduction
J.2 Growth in the Pharma Market
J.3 Reasons for Growth
J.4 New Product Lines
J.5 Opportunities in CNS Disorders & Oncology Research
J.6 Commercialization of Dormant Compounds
J.7 Generic/Biosimilar Versions of Biologics

K. Challenges Facing the Global Pharmaceutical Industry
K.1 Parallel Trade
K.2 Rising Cost of Healthcare
K.3 Immense Pressure on Industry Revenues
K.4 Uncertainty in Pipeline
K.5 Increasing Risks
K.6 Issues with Outcome-based Pricing

N. Offshoring in the Pharmaceutical Sector
N.1 Introduction
N.1.1 What is Offshoring?
N.1.2 Analyzing the Pharma Value Chain
N.1.3 Employment Scenario of the Pharmaceutical Industry
N.1.4 Why Offshore?
N.1.5 Primary Offshoring Locations
N.2 Offshoring of R&D
N.2.1 India
N.2.2 China
N.2.3 Growth Factors
N.2.4 Challenges & Barriers to Offshoring R&D
N.3 Offshoring of Pharmaceutical Manufacturing Processes
N.3.1 Overview
N.3.2 Biologics Manufacturing
N.3.3 API Manufacturing
N.3.4 Final Dosage Manufacturing
N.3.5 Growth Factors
N.3.6 Challenges & Barriers to Offshoring Manufacturing Processes

Section 2: Analyzing the Global Pharmaceutical Markets

A. Pharmaceutical Industry in Australia
A.1 Industry Statistics
A.2 Industry Value Analysis
A.3 Geographic Segmentation
A.4 Industry Trends
A.5 Production Trends
A.6 Market Share Analysis
A.7 Competition in the Industry
A.8 Industry Outlook

B. Pharmaceutical Industry in Belgium
B.1 Industry Statistics
B.2 Industry Value Analysis
B.3 Geographic Segmentation
B.4 Market Share Analysis
B.5 Competition in the Industry
B.6 Industry Outlook

C. Pharmaceutical Industry in Brazil
C.1 Industry Statistics
C.2 Industry Value Analysis
C.3 Geographic Segmentation
C.4 Market Share Analysis
C.5 Competition in the Industry
C.6 Industry Outlook

D. Pharmaceutical Industry in Canada
D.1 Industry Statistics
D.2 Industry Value Analysis
D.3 Geographic Segmentation
D.4 Market Share Analysis
D.5 Competition in the Industry
D.6 Industry Outlook

E. Pharmaceutical Industry in China
E.1 Industry Statistics
E.2 Industry Value Analysis
E.3 Geographic Segmentation
E.4 Industry Trends
E.5 Production Trends
E.6 Regulatory Framework
E.7 Market for Traditional Chinese Medicine
E.8 Market Share Analysis
E.9 Competition in the Industry
E.10 Industry Outlook

F. Pharmaceutical Industry in Czech Republic
F.1 Industry Statistics
F.2 Industry Value Analysis
F.3 Geographic Segmentation
F.4 Market Share Analysis
F.5 Competition in the Industry
F.6 Industry Outlook

G. Pharmaceutical Industry in Denmark
G.1 Industry Statistics
G.2 Industry Value Analysis
G.3 Geographic Segmentation
G.4 Market Share Analysis
G.5 Competition in the Industry
G.6 Industry Outlook

H. Pharmaceutical Industry in France
H.1 Industry Statistics
H.2 Industry Value Analysis
H.3 Geographic Segmentation
H.4 Market Share Analysis
H.5 Competition in the Industry
H.6 Industry Outlook

I. Pharmaceutical Industry in Germany
I.1 Industry Statistics
I.2 Industry Value Analysis
I.3 Geographic Segmentation
I.4 Market Share Analysis
I.5 Competition in the Industry
I.6 Industry Outlook

J. Pharmaceutical Industry in Hungary
J.1 Industry Statistics
J.2 Industry Value Analysis
J.3 Geographic Segmentation
J.4 Market Share Analysis
J.5 Competition in the Industry
J.6 Industry Outlook

K. Pharmaceutical Industry in India
K.1 Industry Statistics
K.2 Industry Value Analysis
K.3 Geographic Segmentation
K.4 Industry Trends
K.5 Production Trends
K.6 Market Share Analysis
K.7 Competition in the Industry
K.8 Industry Outlook

L. Pharmaceutical Industry in Italy
L.1 Industry Statistics
L.2 Industry Value Analysis
L.3 Geographic Segmentation
L.4 Market Share Analysis
L.5 Competition in the Industry
L.6 Industry Outlook

M. Pharmaceutical Industry in Japan
M.1 Industry Statistics
M.2 Industry Value Analysis
M.3 Geographic Segmentation
M.4 Industry Trends
M.5 Production Trends
M.6 Market Share Analysis
M.7 Competition in the Industry
M.8 Industry Outlook

N. Pharmaceutical Industry in Mexico
N.1 Industry Statistics
N.2 Industry Value Analysis
N.3 Geographic Segmentation
N.4 Market Share Analysis
N.5 Competition in the Industry
N.6 Industry Outlook

O. Pharmaceutical Industry in Netherlands
O.1 Industry Statistics
O.2 Industry Value Analysis
O.3 Geographic Segmentation
O.4 Market Share Analysis
O.5 Competition in the Industry
O.6 Industry Outlook

P. Pharmaceutical Industry in New Zealand
P.1 Industry Statistics
P.2 Industry Value Analysis
P.3 Geographic Segmentation
P.4 Market Share Analysis
P.5 Competition in the Industry
P.6 Industry Outlook

Q. Pharmaceutical Industry in Norway
Q.1 Industry Statistics
Q.2 Industry Value Analysis
Q.3 Geographic Segmentation
Q.4 Market Share Analysis
Q.5 Competition in the Industry
Q.6 Industry Outlook

R. Pharmaceutical Industry in Poland
R.1 Industry Statistics
R.2 Industry Value Analysis
R.3 Geographic Segmentation
R.4 Market Share Analysis
R.5 Competition in the Industry
R.6 Industry Outlook

S. Pharmaceutical Industry in Russia
S.1 Industry Statistics
S.2 Industry Value Analysis
S.3 Geographic Segmentation
S.4 Market Share Analysis
S.5 Competition in the Industry
S.6 Industry Outlook

T. Pharmaceutical Industry in Singapore
T.1 Industry Statistics
T.2 Industry Value Analysis
T.3 Geographic Segmentation
T.4 Market Share Analysis
T.5 Competition in the Industry
T.6 Industry Outlook

U. Pharmaceutical Industry in South Africa
U.1 Industry Statistics
U.2 Industry Value Analysis
U.3 Geographic Segmentation
U.4 Market Share Analysis
U.5 Competition in the Industry
U.6 Industry Outlook

V. Pharmaceutical Industry in South Korea
V.1 Industry Statistics
V.2 Industry Value Analysis
V.3 Geographic Segmentation
V.4 Market Share Analysis
V.5 Competition in the Industry
V.6 Industry Outlook

W. Pharmaceutical Industry in Spain
W.1 Industry Statistics
W.2 Industry Value Analysis
W.3 Geographic Segmentation
W.4 Market Share Analysis
W.5 Competition in the Industry
W.6 Industry Outlook

X. Pharmaceutical Industry in Sweden
X.1 Industry Statistics
X.2 Industry Value Analysis
X.3 Geographic Segmentation
X.4 Market Share Analysis
X.5 Competition in the Industry
X.6 Industry Outlook

Y. Pharmaceutical Industry in Taiwan
Y.1 Industry Statistics
Y.2 Industry Value Analysis
Y.3 Geographic Segmentation
Y.4 Market Share Analysis
Y.5 Competition in the Industry
Y.6 Industry Outlook

Z. Pharmaceutical Industry in United Kingdom
Z.1 Industry Statistics
Z.2 Industry Value Analysis
Z.3 Geographic Segmentation
Z.4 Market Share Analysis
Z.5 Competition in the Industry
Z.6 Industry Outlook

AA. Pharmaceutical Industry in the United States
AA.1 Industry Statistics
AA.2 Industry Value Analysis
AA.3 Geographic Segmentation
AA.4 Market Share Analysis
AA.5 Competition in the Industry
AA.6 Industry Outlook

Section 3: Analyzing the Major Market Players

A. Abbott Laboratories
A.1 Corporate Profile
A.2 Business Segment Analysis
A.3 Financial Analysis
A.4 Ratio Analysis
A.5 Major Products & Services
A.6 SWOT Analysis

B. Allergan, Inc.
B.1 Corporate Profile
B.2 Business Segment Analysis
B.3 Financial Analysis
B.4 Ratio Analysis
B.5 Major Products & Services
B.6 SWOT Analysis

C. Amgen, Inc.
C.1 Corporate Profile
C.2 Business Segment Analysis
C.3 Financial Analysis
C.4 Ratio Analysis
C.5 Major Products & Services
C.6 SWOT Analysis

D. Apotex, Inc.
D.1 Corporate Profile
D.2 Business Segment Analysis
D.3 Financial Analysis
D.4 Ratio Analysis
D.5 Major Products & Services
D.6 SWOT Analysis

E. Aspen Pharmacare Holdings Limited
E.1 Corporate Profile
E.2 Business Segment Analysis
E.3 Financial Analysis
E.4 Ratio Analysis
E.5 Major Products & Services
E.6 SWOT Analysis

F. Astellas Pharma
F.1 Corporate Profile
F.2 Business Segment Analysis
F.3 Financial Analysis
F.4 Ratio Analysis
F.5 Major Products & Services
F.6 SWOT Analysis

G. AstraZeneca
G.1 Corporate Profile
G.2 Business Segment Analysis
G.3 Financial Analysis
G.4 Ratio Analysis
G.5 Major Products & Services
G.6 SWOT Analysis

H. Baxter International
H.1 Corporate Profile
H.2 Business Segment Analysis
H.3 Financial Analysis
H.4 Ratio Analysis
H.5 Major Products & Services
H.6 SWOT Analysis

I. Bayer AG
I.1 Corporate Profile
I.2 Business Segment Analysis
I.3 Financial Analysis
I.4 Ratio Analysis
I.5 Major Products & Services
I.6 SWOT Analysis

J. Boehringer Ingelheim
J.1 Corporate Profile
J.2 Business Segment Analysis
J.3 Financial Analysis
J.4 Ratio Analysis
J.5 Major Products & Services
J.6 SWOT Analysis

K. Bristol-Myers Squibb
K.1 Corporate Profile
K.2 Business Segment Analysis
K.3 Financial Analysis
K.4 Ratio Analysis
K.5 Major Products & Services
K.6 SWOT Analysis

L. Chugai Pharmaceutical
L.1 Corporate Profile
L.2 Business Segment Analysis
L.3 Financial Analysis
L.4 Ratio Analysis
L.5 Major Products & Services
L.6 SWOT Analysis

M. Daewoong Pharmaceutical Co Ltd.
M.1 Corporate Profile
M.2 Business Segment Analysis
M.3 Financial Analysis
M.4 Ratio Analysis
M.5 Major Products & Services
M.6 SWOT Analysis

N. Daiichi Sankyo Company
N.1 Corporate Profile
N.2 Business Segment Analysis
N.3 Financial Analysis
N.4 Ratio Analysis
N.5 Major Products & Services
N.6 SWOT Analysis

O. Eisai Co., Ltd
O.1 Corporate Profile
O.2 Business Segment Analysis
O.3 Financial Analysis
O.4 Ratio Analysis
O.5 Major Products & Services
O.6 SWOT Analysis

P. Eli Lilly and Company
P.1 Corporate Profile
P.2 Business Segment Analysis
P.3 Financial Analysis
P.4 Ratio Analysis
P.5 Major Products & Services
P.6 SWOT Analysis

Q. F. Hoffmann-La Roche
Q.1 Corporate Profile
Q.2 Business Segment Analysis
Q.3 Financial Analysis
Q.4 Ratio Analysis
Q.5 Major Products & Services
Q.6 SWOT Analysis

R. GlaxoSmithKline Plc
R.1 Corporate Profile
R.2 Business Segment Analysis
R.3 Financial Analysis
R.4 Ratio Analysis
R.5 Major Products & Services
R.6 SWOT Analysis

S. Johnson & Johnson
S.1 Corporate Profile
S.2 Business Segment Analysis
S.3 Financial Analysis
S.4 Ratio Analysis
S.5 Major Products & Services
S.6 SWOT Analysis

T. Lupin Limited
T.1 Corporate Profile
T.2 Business Segment Analysis
T.3 Financial Analysis
T.4 Ratio Analysis
T.5 Major Products & Services
T.6 SWOT Analysis

U. Merck & Co.
U.1 Corporate Profile
U.2 Business Segment Analysis
U.3 Financial Analysis
U.4 Ratio Analysis
U.5 Major Products & Services
U.6 SWOT Analysis

V. Novartis AG
V.1 Corporate Profile
V.2 Business Segment Analysis
V.3 Financial Analysis
V.4 Ratio Analysis
V.5 Major Products & Services
V.6 SWOT Analysis

W. Pfizer
W.1 Corporate Profile
W.2 Business Segment Analysis
W.3 Financial Analysis
W.4 Ratio Analysis
W.5 Major Products & Services
W.6 SWOT Analysis

X. Richter Gedeon Vegyeszeti Gyar Nyrt
X.1 Corporate Profile
X.2 Business Segment Analysis
X.3 Financial Analysis
X.4 Ratio Analysis
X.5 Major Products & Services
X.6 SWOT Analysis

Y. Sanofi SA
Y.1 Corporate Profile
Y.2 Business Segment Analysis
Y.3 Financial Analysis
Y.4 Ratio Analysis
Y.5 Major Products & Services
Y.6 SWOT Analysis

Z. Shanghai Pharmaceuticals Holding Co. Ltd.
Z.1 Corporate Profile
Z.2 Business Segment Analysis
Z.3 Financial Analysis
Z.4 Ratio Analysis
Z.5 Major Products & Services
Z.6 SWOT Analysis

AA. Sumitomo Dainippon Pharma
AA.1 Corporate Profile
AA.2 Business Segment Analysis
AA.3 Financial Analysis
AA.4 Ratio Analysis
AA.5 Major Products & Services
AA.6 SWOT Analysis

BB. Takeda Pharmaceutical Company Limited
BB.1 Corporate Profile
BB.2 Business Segment Analysis
BB.3 Financial Analysis
BB.4 Ratio Analysis
BB.5 Major Products & Services
BB.6 SWOT Analysis

CC. Teva Pharmaceutical Industries
CC.1 Corporate Profile
CC.2 Business Segment Analysis
CC.3 Financial Analysis
CC.4 Ratio Analysis
CC.5 Major Products & Services
CC.6 SWOT Analysis

DD. Aurobindo Pharma Ltd
DD.1 Corporate Profile
DD.2 Business Segment Analysis
DD.3 Financial Analysis
DD.4 Ratio Analysis
DD.5 Major Products & Services

EE. Cadila Healthcare
EE.1 Corporate Profile
EE.2 Business Segment Analysis
EE.3 Financial Analysis
EE.4 Ratio Analysis
EE.5 Major Products & Services

FF. China National Accord Medicines Corporation Ltd
FF.1 Corporate Profile
FF.2 Business Segment Analysis
FF.3 Financial Analysis
FF.4 Ratio Analysis
FF.5 Major Products & Services

GG. Cipla Ltd
GG.1 Corporate Profile
GG.2 Business Segment Analysis
GG.3 Financial Analysis
GG.4 Ratio Analysis
GG.5 Major Products & Services

HH. Dr. Reddy’s Laboratories Limited
HH.1 Corporate Profile
HH.2 Business Segment Analysis
HH.3 Financial Analysis
HH.4 Ratio Analysis
HH.5 Major Products & Services

II. Hanmi Science Co Ltd
II.1 Corporate Profile
II.2 Business Segment Analysis
II.3 Financial Analysis
II.4 Ratio Analysis
II.5 Major Products & Services

JJ. Harbin Pharmaceutical Group Co. Ltd.
JJ.1 Corporate Profile
JJ.2 Business Segment Analysis
JJ.3 Financial Analysis
JJ.4 Ratio Analysis
JJ.5 Major Products & Services

KK. Jubilant Life Sciences Ltd
KK.1 Corporate Profile
KK.2 Business Segment Analysis
KK.3 Financial Analysis
KK.4 Ratio Analysis
KK.5 Major Products & Services

LL. Mylan Laboratories Ltd
LL.1 Corporate Profile
LL.2 Business Segment Analysis
LL.3 Financial Analysis
LL.4 Ratio Analysis
LL.5 Major Products & Services

MM. Pharmstandard OJSC
MM.1 Corporate Profile
MM.2 Business Segment Analysis
MM.3 Financial Analysis
MM.4 Ratio Analysis
MM.5 Major Products & Services

NN. Ranbaxy Laboratories
NN.1 Corporate Profile
NN.2 Business Segment Analysis
NN.3 Financial Analysis
NN.4 Ratio Analysis
NN.5 Major Products & Services

OO. Sun Pharmaceutical Industries
OO.1 Corporate Profile
OO.2 Business Segment Analysis
OO.3 Financial Analysis
OO.4 Ratio Analysis
OO.5 Major Products & Services

PP. Taisho Pharmaceutical Co., Ltd.
PP.1 Corporate Profile
PP.2 Business Segment Analysis
PP.3 Financial Analysis
PP.4 Ratio Analysis
PP.5 Major Products & Services

QQ. Chiesi Farmaceutici SpA

RR. Dong-A Pharmaceutical Co. Ltd

SS. Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.

TT. Yunnan Baiyao Group

Section 4: Glossary of Terms


【レポート販売概要】

■ タイトル:世界の製薬産業分析2015
■ 英文:Analyzing the Global Pharmaceutical Industry 2015
■ 発行日:2015年2月
■ 調査会社:Aruvian’s R’search
■ 商品コード:ARUV50201
■ 調査対象地域:グローバル
  • オートバイADAS(先進運転支援システム)の世界市場:ABS、ACC、TCS、その他
    Global Motorcycle Advanced Driver Assistance System (ADAS) Market: About this market Motorcycle advanced driver assistance system (ADAS) is specifically designed with a safe human-machine interface, which helps in enhancing the safety of the rider and the motorcycle. Technavio’s motorcycle advanced driver assistance system (ADAS) market analysis considers sales from segments including ABS, ACC, TC …
  • 胃腸疾患(GI)検便検査の世界市場:便潜血反応検査(FOBT)、臨床微生物学的検便検査
    About GI stool testing Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the d …
  • 無線LANチップセットの世界市場予測(~2022)
    The Wi-Fi chipset market was valued at USD 15.89 Billion in 2016 and is expected to reach USD 19.72 Billion by 2022, at a CAGR of 3.5% between 2017 and 2022. The growing number of public Wi-Fi hotspots, growth in connected devices ownership, rising demand for WiGig technology, and growth of Wi-Fi technology in enterprise and business are the major drivers for the Wi-Fi chipset market. Wi-Fi has be …
  • 複合イベント処理(CEP)の世界市場予測(~2020)
    MarketsandMarkets forecast the Complex Event Processing market size to grow from USD 1.28 Billion in 2015 to USD 4.95 Billion by 2020, at a compound annual growth rate (CAGR) of 31.1%. The adoption of device based computing and potential growth in demand for enterprise data worldwide are the main drivers of the CEP market. Presently, on-premise based deployment of CEP has the larger share than the …
  • 機械翻訳の世界市場2015-2019
    About Machine Translation Machine translation (MT) is the translation of words by a computer from one language to another. It is one of the major sub-fields of computational linguistics, and deals with statistical or rule-based modeling of natural language. It enables speedy translation of documents and content. It is a cost-effective method employed by several companies to create multilingual con …
  • 小火器の世界市場2016-2020
    About Global Small Arms Market The global small arms market has undergone a major transformation over the last one decade. The long-standing wars in Iraq and Afghanistan have infused several changes in the development and manufacture of small arms by both major countries as well as emerging nations of the world. The close quarter combats (CQC) between various military units and militant groups hav …
  • 世界主要国のエコーウイルス検査(医療機器)市場:サプライヤーシェア及び市場予測
    The report presents a detailed analysis of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Comm …
  • レーダ装置の世界市場展望2017-2026
    According to Stratistics MRC, the Global Radar Systems Market is accounted for $19.25 billion in 2017 and is expected to reach $36.78 billion by 2026 growing at a CAGR of 7.5% during the forecast period. Some of the key factors influencing the market growth include Increased use of radars for unmanned vehicles, improved capabilities of radar systems resulting in greater efficiency and increased R& …
  • 癌バイオマーカーの世界市場:タンパク質バイオマーカー、ジェネティックバイオマーカー
    In this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics developme …
  • 海洋VSAT(超小型地球局)の世界市場2015-2019
    Covering: Growth prospects and market forecast of the global maritime VSAT services market and a segmentation analysis by technology (HTS, L-band, KU-band, and C-band), and by number of terminals (Ka-band, c-band, and Ku-band). Market shares for APAC, Americas, and the EMEA are included in this report. The leading vendors analyzed in this report include Harris Caprock, Hughes, Inmarsat, KVH, RigNe …
  • 皮革製品の世界市場:フットウェア、バック、財布、かばん
    Technavio's market research analyst predicts the leather goods industry to grow at a CAGR of around 4% during the forecast period. The rise in export of leather is the primary driver for the growth of this market. For instance, during 2014, the US exported hides, skins and semi-processed leather which generated a revenue of around USD 3 billion. China, Taiwan, Korea, Mexico, and the European count …
  • Dyslexia:グローバル臨床試験レビューH1, 2013
    Dyslexia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • 旅客情報システム(PIS)の世界市場2015-2019
    Covering: Market forecast and analysis of the global passenger information system market until 2019. Market size and segmentations by products (hardware, software, and services), and by mode of transport (roadways, airways, and railways). It includes market shares for APAC, Americas, and EMEA. Top vendors analyzed by this report include Alstom, Cubic Transportation, GE, Hitachi, and Huawei This re …
  • 世界のカドミウム市場:市場規模、動向、メーカー動向
    Scope The report presents a thorough study of cadmium, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing cadmium production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: cadmium product …
  • 医療用ロボットの世界市場予測(~2023年)
    “The medical robots market is projected to grow at a CAGR of 21.0%.”The medical robots market is projected to reach USD 16.74 billion by 2023 from an estimated USD 6.46 billion in 2018. The major influencing factors driving the growth of this market are advantages offered by robot-assisted training in rehabilitation therapy, increase in funding for medical robot research, technological advancement …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。